These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9786486)
1. Characterization of the extended-spectrum beta-lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary. Pragai Z; Koczian Z; Nagy E J Antimicrob Chemother; 1998 Sep; 42(3):401-3. PubMed ID: 9786486 [No Abstract] [Full Text] [Related]
2. The frequency of extended-spectrum beta-lactamases in isolates of Klebsiella pneumoniae. Katsanis G; Jacoby G J Antimicrob Chemother; 1992 Mar; 29(3):345-6. PubMed ID: 1592702 [No Abstract] [Full Text] [Related]
4. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. Yagi T; Kurokawa H; Shibata N; Shibayama K; Arakawa Y FEMS Microbiol Lett; 2000 Mar; 184(1):53-6. PubMed ID: 10689165 [TBL] [Abstract][Full Text] [Related]
5. Identification of a blaVIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary. Kristóf K; Tóth A; Damjanova I; Jánvári L; Konkoly-Thege M; Kocsis B; Koncan R; Cornaglia G; Szego E; Nagy K; Szabó D J Antimicrob Chemother; 2010 Jun; 65(6):1303-5. PubMed ID: 20410063 [No Abstract] [Full Text] [Related]
6. Class 1 integrons in urinary isolates of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Southern China during the past five years. Sun J; Zheng F; Wang F; Wu K; Wang Q; Chen Q; Yu S; Rui Y Microb Drug Resist; 2013 Aug; 19(4):289-94. PubMed ID: 23573964 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic and molecular characterization of extended-spectrum β-lactamases and AmpC β-lactamases in Klebsiella pneumoniae. Al-Agamy MH Pak J Pharm Sci; 2013 Mar; 26(2):291-8. PubMed ID: 23455199 [TBL] [Abstract][Full Text] [Related]
8. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. Yan JJ; Ko WC; Wu HM; Tsai SH; Chuang CL; Wu JJ J Clin Microbiol; 2004 Nov; 42(11):5337-40. PubMed ID: 15528737 [TBL] [Abstract][Full Text] [Related]
9. Klebsiella pneumoniae strains carrying the chromosomal SHV-11 beta-lactamase gene produce the plasmid-mediated SHV-12 extended-spectrum beta-lactamase more frequently than those carrying the chromosomal SHV-1 beta-lactamase gene. Lee YH; Cho B; Bae IK; Chang CL; Jeong SH J Antimicrob Chemother; 2006 Jun; 57(6):1259-61. PubMed ID: 16595640 [No Abstract] [Full Text] [Related]
10. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae. Pai H; Seo MR; Choi TY Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790 [TBL] [Abstract][Full Text] [Related]
11. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase. Elliott E; Brink AJ; van Greune J; Els Z; Woodford N; Turton J; Warner M; Livermore DM Clin Infect Dis; 2006 Jun; 42(11):e95-8. PubMed ID: 16652304 [TBL] [Abstract][Full Text] [Related]
12. In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases. Kitzis MD; Liassine N; Ferré B; Gutmann L; Acar JF; Goldstein F Antimicrob Agents Chemother; 1990 Sep; 34(9):1783-6. PubMed ID: 2285291 [TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection. Quale JM; Landman D; Bradford PA; Visalli M; Ravishankar J; Flores C; Mayorga D; Vangala K; Adedeji A Clin Infect Dis; 2002 Oct; 35(7):834-41. PubMed ID: 12228820 [TBL] [Abstract][Full Text] [Related]
14. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates]. Xiong Z; Zhu D; Zhang Y; Wang F Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910 [TBL] [Abstract][Full Text] [Related]
15. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates. Giakkoupi P; Tzouvelekis LS; Daikos GL; Miriagou V; Petrikkos G; Legakis NJ; Vatopoulos AC J Clin Microbiol; 2005 Jan; 43(1):494-6. PubMed ID: 15635025 [TBL] [Abstract][Full Text] [Related]
17. Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals. Papagiannitsis CC; Tryfinopoulou K; Giakkoupi P; Pappa O; Polemis M; Tzelepi E; Tzouvelekis LS; ; Vatopoulos AC Int J Antimicrob Agents; 2012 Feb; 39(2):178-80. PubMed ID: 22104281 [No Abstract] [Full Text] [Related]
18. Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea. Jeong SH; Bae IK; Kwon SB; Lee JH; Jung HI; Song JS; Jeong BC; Kim SJ; Lee SH Lett Appl Microbiol; 2004; 39(1):41-7. PubMed ID: 15189286 [TBL] [Abstract][Full Text] [Related]
19. Clonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae in Neonates. Yin D; Dong D; Li K; Zhang L; Liang J; Yang Y; Wu N; Bao Y; Wang C; Hu F Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533245 [TBL] [Abstract][Full Text] [Related]
20. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]